+49 711 500 989 80
deen

Targeting interleukin-6 could help relieve immunotherapy side effects



Targeting interleukin-6 could help relieve immunotherapy side effects

Researchers have identified a novel strategy to reduce immune-related adverse events from immunotherapy treatment by targeting the cytokine interleukin-6 (IL-6).

Materials provided by University of Texas M. D. Anderson Cancer Center. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

3rd October 2022

Researchers discover new molecular driver of retinoblastoma

Read more
3rd October 2022

New epigenetic markers for prostate cancer discovered

Read more
1st October 2022

Disarming the body's defenders

Read more